Telegraph.co.uk |
Glaxo in for competition after Hikma's generic asthma drug passes major milestone
Telegraph.co.uk Cheap versions of one of GlaxoSmithKline's top-selling asthma drugs could be available to patients as early as next year. Jordanian pharmaceuticals company Hikma moved one step closer to getting a generic version of Glaxo's Advair Diskus inhaler onto … Cipla's rival Hikma gets asthma drug nod in the US Vectura and Hikma's generic of Advair Diskus accepted for filing by US FDA Vectura Group PLC and Hikma shares given FDA boost |
View full post on asthma – Google News